Positions

Selected Publications

Academic Article

Year Title Altmetric
2016 The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin 2016
2016 Monoclonal antibodies to Shigella lipopolysaccharide are useful for vaccine production 2016
2016 Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile 2016
2016 Discovery and characterization of human-urine utilization by asymptomaticbacteriuria-causing Streptococcus agalactiae 2016
2015 Loss of vancomycin-resistant enterococcus fecal dominance in an organ transplant patient with Clostridium difficile colitis after fecal microbiota transplant 2015
2014 Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus 2014
2013 Asymptomatic bacteriuria: Prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection 2013
2013 Erratum: Diversity of group B streptococcus serotypes causing urinary tract infection in adults (Journal of Clinical Microbiology (2009) 47:7 (2055-2060)) 2013
2012 Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients 2012
2012 Device for carrying blood samples at 37°C for cryoglobulin test 2012
2012 Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection 2012
2012 Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: A case report 2012
2011 Development of an automated and multiplexed serotyping assay for Streptococcus pneumoniae 2011
2011 Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin 2011
2010 Hit-and-run stimulation: A novel concept to reactivate latent HIV-1 infection without cytokine gene induction 2010
2010 Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1α 2010
2009 Diversity of group B streptococcus serotypes causing urinary tract infection in adults 2009
2008 PIR-B-deficient mice are susceptible to Salmonella infection 2008
2006 Risk of infection and tracking of work-related infectious diseases in the funeral industry 2006
2006 Case report: Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother 2006
2006 Validation of a multiplex pneumococcal serotyping assay with clinical samples 2006
2006 Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother. 2006
2005 Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized mice and can protect splenectomized mice from infection with Streptococcus pneumoniae 2005
2005 Long-term molecular analysis of tuberculosis strains in Alabama, a state characterized by a largely indigenous, low-risk population 2005
2005 Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity 2005
2005 Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies 2005
2005 Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae 2005
2004 Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040)) 2004
2004 Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility and role in protection from superoxide 2004
2004 PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin 2004
2003 Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South Korea 2003
2003 Evaluation of an extensive tuberculosis contact investigation in an urban community and jail 2003
2003 The Rapid Development of Fluoroquinolone Resistance in M. tuberculosis [7] 2003
2003 Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae 2003
2003 Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides 2003
2003 Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America 2003
2003 Vancomycin-resistant enterococci: 15 years and counting 2003
2003 Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. 2003
2003 Ligase chain reaction. 2003
2002 Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis 2002
2002 Cross-jurisdictional transmission of Mycobacterium tuberculosis in Maryland and Washington, D.C., 1996-2000, linked to the homeless 2002
2002 Molecular differentiation of Mycobacterium tuberculosis strains without IS6110 insertions 2002
2002 Molecular epidemiology of tuberculosis in a low-to moderate-incidence state: Are contact investigations enough? 2002
2002 Molecular epidemiology of tuberculosis in a sentinel surveillance population 2002
2002 Molecular typing of Mycobacterium tuberculosis strains with a common two-band IS6110 pattern 2002
2002 Expression, autoregulation, and DNA binding properties of the Mycobacterium tuberculosis TrcR response regulator 2002
2001 In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children 2001
2001 Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes 2001
2001 Epidemiologic usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 2001
2001 Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype 2001
2001 Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobe 2001
2001 Value of Mycobacterium tuberculosis fingerprinting as a tool in a rural state surveillance program 2001
2000 The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters) 2000
2000 Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children 2000
2000 Human C-reactive protein is protective against fatal Salmonella enterica serovar Typhimurium infection in transgenic mice 2000
1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimens 1999
1999 Spot sputum screening: Evaluation of an intervention in two homeless shelters 1999
1999 In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins 1999
1998 Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimens 1998
1998 Restriction fragment length polymorphism screening of Mycobacterium tuberculosis isolates: Population surveillance for targeting disease transmission in a community 1998
1997 Avirulence of LT2 strains of Salmonella typhimurium results from a defective rpoS gene 1997
1997 Bacterial phenotypes mediated by mviA and their relationship to the mouse virulence of Salmonella typhimurium 1997
1996 Transmission of mycobacterium tuberculosis to recipients of single lung transplants from the same donor 1996
1996 The predicted amino acid sequence of the Salmonella typhimurium virulence gene mviA+ strongly indicates that MviA is a regulator protein of a previously unknown S. typhimurium response regulator family 1996
1996 Acid shock induction of RpoS is mediated by the mouse virulence gene mviA of Salmonella typhimurium 1996
1996 Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium 1996
1996 Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor 1996
1995 Laboratory contamination of Mycobacterium tuberculosis cultures 1995
1994 Mouse Virulence Gene A (mviA+) Is a Pleiotropic Regulator of Gene Expression in Salmonella typhimurium 1994
1994 The intracellular nature of Salmonella infection during the early stages of mouse typhoid. 1994
1993 In vivo administration of the anticancer agent bryostatin 1 activates platelets and neutrophils and modulates protein kinase C activity. 1993
1992 A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells 1992
1992 Detection of DNA in southern blots by chemiluminescence is a sensitive and rapid technique 1992
1992 In Vivo Administration of Bryostatin 1, a Protein Kinase C Activator, Decreases Murine Resistance to Salmonella typhimurium 1992
1991 The salmonella typhlmurium locus mv/a regulates virulence in itys but not ityr mice: Functional mv/a results in avirulence; mutant (nonfunctional) mv/a results in virulence 1991
1991 A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice 1991
1991 A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium 1991
1991 Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth 1991
1990 The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing 1990
1989 Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens 1989
1989 Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV) 1989
1986 Effects of in vitro growth phase on the pathogenesis of Salmonella typhimurium in mice 1986
1986 Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice. 1986
1986 Genetic control of the susceptibility to pneumococcal infection. 1986
1986 Genetic mapping of novel virulence determinants of Salmonella typhimurium to the region between trpD and supD 1986
1986 Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus 1986
1986 Salmonella typhimurium virulence genes necessary to exploit the Ity(s/s) genotype of the mouse 1986
1985 Induction of germ-line anti-α1-3 dextran antibody responses in mice by members of the enterobacteriaceae family 1985
1985 The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid 1985
1984 Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia 1984
1981 A genetic locus responsible for salmonella susceptibility in BSVS mice is not responsible for the limited T-dependent immune responsiveness of BSVS mice 1981

Research Overview

  • Clinical parasitology in Alabama, investigating zoonotic parasites that can infect humans. Diagnostic Mycobacteriology, mainly decreasing time to diagnosis of Mycobacterial infections

    • Full Name

  • William Benjamin